PredictAD launched an impressive research collaboration aimed at developing new diagnostic procedures for patients with Alzheimer’s. Funded by the European Union, it includes a consortium of leading research European institutions.

Yale University researchers blocked a common immune system response. The result? It cleared up plaques associated with Alzheimer’s. Treated mice recovered some lost memory.

Chronic bacterial infections and associated viral infections are emerging as key players in Alzheimer's. Treating these with available medications may result in regression and even prevention of Alzheimer's.

Physical chemists show precisely how a minor, seemingly inconsequential mutation results in unexpected changes in a very delicate chemical balance, creating the build-up of the toxic by-products behind Alzheimer's.

SEE VIDEO

In a new study, long-term use of ibuprofen and other drugs commonly used for aches and pains was associated with a lower risk of Alzheimer’s disease.

14 leading researchers meet in Paris to discuss Alzheimer's. Read their detailed overview of what we know about Alzheimer's today in the following article, "Intracellular Traffic and Neurodegenerative Disorders."